Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04368793|
Recruitment Status : Recruiting
First Posted : April 30, 2020
Last Update Posted : July 17, 2020
|Condition or disease||Intervention/treatment|
|COVID-2019 Pneumonia Pulmonary Rehabilitation||Behavioral: Remote pulmonary rehabilitation|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Intelligence-based Remote Pulmonary Rehabilitation and Efficacy Among Discharged COVID-19 Patients|
|Actual Study Start Date :||April 6, 2020|
|Estimated Primary Completion Date :||December 31, 2020|
|Estimated Study Completion Date :||December 31, 2021|
Discharged COVID-19 patient cohort
All enrolled participants will be given 8 weeks (online 2 weeks + offline 6 weeks) pulmonary rehabilitation intervention, and will be followed up for at least one year, to assess their adherence and efficacy of the rehabilitation program.
Behavioral: Remote pulmonary rehabilitation
The pulmonary rehabilitation intervention includes respiratory exercise, barehanded aerobic training, exercise prescription of elastic band impedance training, respiratory muscle strength training, etc.
- Six-minute walking distance (6MWD) [ Time Frame: One year ]Walking distance within six minutes
- Pulmonary function [ Time Frame: One year ]Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), etc.
- Respiratory muscle strength [ Time Frame: One year ]Maximal inspiratory pressure, maximal expiratory pressure, etc.
- Physical fitness assessment [ Time Frame: One year ]Two-minute walking test, short physical performance battery, grip strength of both upper limbs, knee extension strength of both lower limbs, etc.
- Symptom [ Time Frame: One year ]Modified British Medical Research Council (mMRC) dyspnea scale, etc.
- Psychological evaluation [ Time Frame: One year ]Self-training depression scale (SDS) and self-rating anxiety scale (SAS)
- Quality of life [ Time Frame: One year ]36-item short-form health survey (SF-36), etc.
- Physical activity [ Time Frame: One year ]International physical activity questionnaire (IPAQ)
- Proportion of returning to society [ Time Frame: One year ]Proportions of returning to routine work and normal life
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04368793
|Contact: Geyi Wen, Resident||+86 email@example.com|
|Contact: Lulu Yang, Resident||+86 firstname.lastname@example.org|
|Wuhan Lung Hospital||Recruiting|
|Wuhan, Hubei, China, 100191|
|Contact: Guangyun Guo, Doctor +86 13886806423|
|Wuhan Central Hospital||Recruiting|
|Wuhan, Hubei, China, 430014|
|Contact: Yi Hu, Doctor +86 13995618974|
|Zhongnan Hospital of Wuhan University||Recruiting|
|Wuhan, Hubei, China, 430071|
|Contact: Zhenshun Cheng, Doctor +86 13627288300|
|Principal Investigator:||Ting Yang, Prof.||China-Japan Friendship Hospital|